1. 49-72 of 521 « 1 2 3 4 5 6 ... 20 21 22 »
    1. Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors

      Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors

      Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announced the appointment of Jennifer L. Aaker, Ph.D. to its board of directors, expanding membership to nine directors. Dr. Aaker is the General Atlantic Professor at the Stanford Graduate School of Business, and a leading behavioral scientist, scholar, and best-selling author. Her unique expertise helps companies and leaders build cultures that harness purpose, story and technologies, and facilitates improved implementation of novel strategies that enhance growth and societal impact...

      Read Full Article
    2. Overstock Appoints Barbara Messing to its Board of Directors

      Overstock Appoints Barbara Messing to its Board of Directors

      The Board of Directors of Overstock.com, Inc.(NASDAQ:OSTK) appointed Barbara Messing as its newest independent director on August 4, 2020. Messing is known for her success in implementing data-driven innovations during her more than two decades of experience in global retail and e-commerce and has been an integral part of leading profitable growth in complex and growth-focused companies...

      Read Full Article
    3. The RealReal Appoints Two Women to Board of Directors

      The RealReal Appoints Two Women to Board of Directors

      Today, The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, consigned luxury goods—announced Caretha Coleman (Principal of Coleman Consulting) and Carol Melton (CEO and Founder of Adeft Capital) have joined its Board of Directors, effective immediately. These appointments make The RealReal’s board 50 percent female...

      Read Full Article
      Mentions: Nasdaq Women Female
    4. Biopharmaceutical Leader Robert J. Spiegel, Md, FACP Appointed to the Athenex Board of Directors

      Biopharmaceutical Leader Robert J. Spiegel, Md, FACP Appointed to the Athenex Board of Directors

      Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the appointment of Robert J. Spiegel, MD, FACP, a renowned biotech and pharmaceutical executive, to its Board of Directors...

      Read Full Article
    5. L.B. Foster Announces the Appointment of Raymond T. Betler to Its Board of Directors

      L.B. Foster Announces the Appointment of Raymond T. Betler to Its Board of Directors

      L.B. Foster Company (NASDAQ: FSTR), a leading manufacturer and distributor of products and provider of services for transportation and energy infrastructure, announced today that Raymond T. Betler has been appointed to the Company’s Board of Directors effective August 3, 2020. Mr. Betler brings a wide range of knowledge and skills to the board that includes more than four decades of experience in the transportation industry leading up to his most recent position serving as President & Chief Executive Officer of Wabtec (NYSE:WAB). On July 1, 2019, Mr. Betler retired as President & CEO of Wabtec after holding the position ...

      Read Full Article
      Mentions: Nasdaq NYSE AMP
    6. Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors

      Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors

      NEW YORK, Royalty Pharma (Nasdaq: RPRX) today announced the appointments of Henry A. Fernandez and Ted W. Love, M.D. to the company's Board of Directors, effective immediately. Mr. Fernandez is Chairman and Chief Executive Officer of MSCI Inc., a leading global provider of investment decision support tools. Dr. Love is President and Chief Executive Officer of Global Blood Therapeutics, a biopharmaceutical company focused on the treatment and care of sickle cell disease...

      Read Full Article
    7. Caladrius Biosciences Appoints Dr. Michael H. Davidson to Board of Directors

      Caladrius Biosciences Appoints Dr. Michael H. Davidson to Board of Directors

      Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not simply manage, disease, today announced the appointment of Michael H. Davidson, MD to its Board of Directors. Dr. Davidson, an industry leader and expert in preventative cardiology and lipidology, is the Founder and Chief Scientific Officer of Corvidia Therapeutics, which recently announced its sale to Novo-Nordisk for $2.1 billion...

      Read Full Article
      Mentions: Nasdaq Sale Founder
    8. Michael A. Kelly Appointed to DMC Global’s Board of Directors

      Michael A. Kelly Appointed to DMC Global’s Board of Directors

      DMC Global Inc. (Nasdaq: BOOM) today announced its board of directors has elected Michael A. Kelly as an independent director. Mr. Kelly joins the DMC board with an extensive background in finance, operations and information systems management.  He is president of Sentry Hill Partners, LLC, a global life sciences transformation and management consulting business founded by Mr. Kelly in 2018...

      Read Full Article
    9. Otelco Agrees to be Acquired by Oak Hill Capital

      Otelco Agrees to be Acquired by Oak Hill Capital

      Otelco Inc. (Nasdaq: OTEL) (“Otelco” or the “Company”), has entered into a definitive agreement to be acquired by affiliates formed by Oak Hill Capital (“Oak Hill”), a private equity firm, for $11.75 per share in cash, which represents an equity purchase price of $40.6 million and an enterprise value of $105.6 million...

      Read Full Article
    10. KLX Energy Services Stockholders Approve Stock Issuance in Connection with the Proposed Merger with Quintana Energy Services

      KLX Energy Services Stockholders Approve Stock Issuance in Connection with the Proposed Merger with Quintana Energy Services

      KLX Energy Services Holdings, Inc. (“KLXE” or the “Company”) (NASDAQ: KLXE ), a leading U.S. onshore provider of mission critical oilfield services, announced that KLXE’s stockholders have approved the issuance of KLXE’s common stock (the “Stock Issuance Proposal”) in connection with the proposed merger of an indirect wholly owned subsidiary of KLXE with and into Quintana Energy Services Inc. (“QES”) (NYSE: QES ) pursuant to an agreement and plan of merger, dated as of May 3, 2020 (the “Merger Agreement”), by and among QES, KLXE and two wholly owned subsidiaries of KLXE...

      Read Full Article
    11. Verrica Pharmaceuticals Announces Dr. Lawrence Eichenfield Joins Board of Directors

      Verrica Pharmaceuticals Announces Dr. Lawrence Eichenfield Joins Board of Directors

      Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, today announced that Dr. Lawrence Eichenfield, Chief of Pediatric and Adolescent Dermatology, Rady Children’s Hospital, San Diego, CA, is joining the Company’s Board of Directors (the “Board”), effective August 1, 2020. Dr. Eichenfield will replace Dr. Gary Goldenberg who will be stepping down from the Board to assume the role of Verrica’s Chief Medical Officer, which the Company announced separately today...

      Read Full Article
    12. Kourtney Gibson Elected to MarketAxess Board of Directors

      Kourtney Gibson Elected to MarketAxess Board of Directors

      MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade services for global fixed-income markets, today announced the election of Kourtney Gibson to its Board of Directors, effective July 16, 2020...

      Read Full Article
    13. Homology Medicines Appoints Jeff Poulton to the Board of Directors

      Homology Medicines Appoints Jeff Poulton to the Board of Directors

      Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Jeff Poulton has been appointed to the Board of Directors. Mr. Poulton is the Chief Financial Officer at Alnylam. Mr. Poulton brings 25 years of experience to Homology’s Board of Directors, including leading finance, business development and commercial operations at companies using differentiated technologies to develop treatments for patients with rare diseases...

      Read Full Article
    14. Linda Childears Elected to Alpine Bank Board of Directors

      Linda Childears Elected to Alpine Bank Board of Directors

      Glenwood Springs, Colorado, Linda Childears, president emeritus of the Daniels Fund, has been elected to the Board of Directors of Alpine Bank, Board Chairman Bob Young announced today. “With our recent addition of four Front Range Alpine Banks, we felt it important to find a board member that will make a valuable contribution to our organization,” said Young...

      Read Full Article
    15. Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board

      Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board

      Teligent, Inc. (Nasdaq: TLGT, a New Jersey based specialty generic pharmaceutical company, is pleased to announce that John Celentano, a current independent director of Teligent, has been appointed Chairman of Teligent's Board of Directors, replacing James C. Gale who opted to not stand for reelection to Teligent’s board of directors in order to devote more time to other business interests...

      Read Full Article
    49-72 of 521 « 1 2 3 4 5 6 ... 20 21 22 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content